Morphine IR & ER

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
SPE2D2-25-R-0012
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is seeking a national contract to supply morphine immediate release (IR) and extended release (ER) tablets for multiple federal agencies. The solicitation (SPE2D2-25-R-0012) covers five different tablet strengths in 100-count bottles: IR 15mg and 30mg, and ER 15mg, 30mg, and 60mg. This is a Lowest Price Technically Acceptable (LPTA) procurement, meaning vendors will be evaluated primarily on meeting minimum technical requirements and offering the lowest price. Potential contractors must submit electronic proposals through the Defense Logistics Agency Internet Bid Board System (DIBBS) by June 26, 2025, at 3:00 PM EST, which represents an extended submission deadline from the original June 12 date. Offerors are required to comply with FDA regulations, provide detailed manufacturing information, and include comprehensive documentation such as pricing, past performance records, and other specified materials.

The solicitation is not set aside for any specific category of business and will serve multiple federal agencies including the Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service. The contract will be a firm-fixed-price requirements contract with a base year and four option years, not exceeding a total of five years. Estimated annual quantities for the morphine tablets range from 691 to 5,640 bottles across different strengths, to be distributed through Pharmaceutical Prime Vendors. The procurement falls under NAICS Category 325412 for Pharmaceutical Preparation Manufacturing and PSC Category 6505 for Drugs and Biologicals. While specific award values are not explicitly stated, the multi-year, multi-agency nature of the contract suggests a potentially significant procurement opportunity for qualified pharmaceutical manufacturers.

Notice text

SPE2D2-25-R-0012 Morphine IR & ER Solicitation

Files

File Type Posted
SPE2D225R00120001 released.pdf PDF
Morphine IR and ER SPE2D225R0012 Solicitation.pdf PDF

Notice history

Notice Type Posted
Morphine IR & ER Award Award Notice
This notice Latest solicitation Solicitation
Morphine IR & ER Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside
Epinephrine Injector NAICS 325412 Medical Supply Chain No set-aside
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity